Anti PD-1 treatment increases [(18)F]FDG uptake by cancer cells in a mouse B16F10 melanoma model

BACKGROUND: Programmed cell death 1 (PD-1) inhibitors act as immune checkpoint inhibitors and are more effective for improving survival time with less toxicity as compared with conventional chemotherapies. In anti PD-1 therapy, it is important to evaluate metabolism in the cancer microenvironment, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Mayu, Yasui, Hironobu, Higashikawa, Kei, Nakajima, Kohei, Takakura, Hideo, Shiga, Tohru, Kuge, Yuji, Ogawa, Mikako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095935/
https://www.ncbi.nlm.nih.gov/pubmed/30117062
http://dx.doi.org/10.1186/s13550-018-0433-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095935/
https://www.ncbi.nlm.nih.gov/pubmed/30117062
http://dx.doi.org/10.1186/s13550-018-0433-1

Ejemplares similares